Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03882788 · ClinicalTrials.gov registry record · NA
The Effect of Anesthesia on Neurodevelopmental Outcome (NDO)
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT03882788: Completed NA study, sponsored by Stanford University.
NCT03882788 is a NA study that has completed, run by Stanford University. The registered enrollment target is 153 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03882788, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether the type of anesthesia, narcotic-based versus inhalational anesthesia administered during cardiopulmonary bypass (CPB) surgery contributes to the wide variation in neurologic recovery and developmental outcome after surgery in infants with congenital heart disease.
Interventions
- DRUG Isoflurane
- DRUG Fentanyl (high dose)
- DRUG Fentanyl (low dose)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2013-04-22 |
| Est. Completion | 2020-11-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03882788
The ClinicalTrials.gov registry entry for NCT03882788 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Isoflurane is the first listed.
NCT03882788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03882788 about?
NCT03882788 is a clinical study titled "The Effect of Anesthesia on Neurodevelopmental Outcome (NDO)". The purpose of this study is to assess whether the type of anesthesia, narcotic-based versus inhalational anesthesia administered during cardiopulmonary bypass (CPB) surgery contributes to the wide variation in neurologic recovery and developmental outcome after surgery in infants with congenital he...
What is the current status of trial NCT03882788?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2013-04-22. Estimated completion is 2020-11-19.
What interventions are being tested in trial NCT03882788?
The interventions under investigation include: Isoflurane (DRUG), Fentanyl (high dose) (DRUG), Fentanyl (low dose) (DRUG).
Who is sponsoring clinical trial NCT03882788?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.